April 2010
Volume 51, Issue 13
ARVO Annual Meeting Abstract  |   April 2010
Adherence to Topical Glaucoma Medication During Hospitalization
Author Affiliations & Notes
  • S. J. Yousuf
    Ophthalmology, Howard University Hospital, Washington, Dist. of Columbia
  • L. S. Jones
    Ophthalmology, Howard University Hospital, Washington, Dist. of Columbia
  • Footnotes
    Commercial Relationships  S.J. Yousuf, None; L.S. Jones, Allergan;Alcon, C.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 197. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. J. Yousuf, L. S. Jones; Adherence to Topical Glaucoma Medication During Hospitalization. Invest. Ophthalmol. Vis. Sci. 2010;51(13):197.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

To describe the patterns and predictors of adherence to topical glaucoma medications during hospitalization for medical disease.


Medical records of all patients hospitalized with a secondary diagnosis of glaucoma between January 2006 and March 2009 were reviewed. Baseline characteristics of all patients were recorded including age, sex, ethnicity, primary diagnosis and length of stay. The out-patient topical glaucoma medications known on admission and prescribed at the time of admission were recorded, and the number of out-patient and in-patient systemic medications were tracked. Adherence was defined as receiving ≥ 75% of expected doses during hospitalization, based on the out-patient regimen.


Baseline characteristics of patients are displayed in Table 1. Of the 184 patients included, 51.6% achieved adherence. Knowing (p<0.01) and prescribing (p<0.01) the complete out-patient regimen upon admission were associated with adherence. Doses were most commonly omitted due to failure to prescribe (72.3%). Discharge instructions correctly listed the out-patient regimen 54.3% of the time.


Adherence to topical glaucoma medications was sub-optimal during hospitalization, and this may be related to poor reporting of the out-patient regimen upon admission. The effect of hospitalization may be a factor to consider in future studies of adherence and when evaluating glaucoma patients after hospitalization.  

Keywords: clinical (human) or epidemiologic studies: risk factor assessment 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.